The burgeoning field of obesity management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These groundbreaking therapies represent a https://ihannauujs962861.wiki-cms.com/8088015/glp_3_receptor_agonists_retatrutide_trizepatide